The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC

Abstract Although neurohormones and Renin‐Angiotensin‐Aldosterone‐System (RAAS) components are important predictors of cardiovascular mortality (CVM), their importance for predicting outcomes in patients with/without RAAS‐blockers and different degrees of arterial stiffness is less understood. We th...

Full description

Bibliographic Details
Main Authors: Babak Yazdani, Graciela E. Delgado, Marcus E. Kleber, Gökhan Yücel, Faeq Husain‐Syed, Thomas D. Kraemer, Jan Jochims, Jan Leipe, Winfried März, Bernhard K. Krämer
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:The Journal of Clinical Hypertension
Subjects:
Online Access:https://doi.org/10.1111/jch.14593
_version_ 1827778868123009024
author Babak Yazdani
Graciela E. Delgado
Marcus E. Kleber
Gökhan Yücel
Faeq Husain‐Syed
Thomas D. Kraemer
Jan Jochims
Jan Leipe
Winfried März
Bernhard K. Krämer
author_facet Babak Yazdani
Graciela E. Delgado
Marcus E. Kleber
Gökhan Yücel
Faeq Husain‐Syed
Thomas D. Kraemer
Jan Jochims
Jan Leipe
Winfried März
Bernhard K. Krämer
author_sort Babak Yazdani
collection DOAJ
description Abstract Although neurohormones and Renin‐Angiotensin‐Aldosterone‐System (RAAS) components are important predictors of cardiovascular mortality (CVM), their importance for predicting outcomes in patients with/without RAAS‐blockers and different degrees of arterial stiffness is less understood. We therefore analyzed long‐term data from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study in 3316 patients subdivided according to pulse pressure (PP) and RAAS‐blocker use. Patients on RAAS‐inhibition had higher renin and noradrenaline, lower aldosterone and aldosterone/renin quotient (ARQ). Renin and noradrenaline significantly predicted CVM in patients without RAAS‐blocker (HR = 1.17, 1.15) and in patients receiving angiotensin‐converting‐enzyme (ACE) inhibitors (HR = 1.17, 1.29), whereas aldosterone predicted CVM only in patients receiving ACE‐inhibitors (HR = 1.13). CVM was predicted independently from PP by renin, noradrenaline and angiotensin II. Independently from RAAS inhibition renin decreased and ARQs increased with rising PP. Furthermore, noradrenaline increased with PP, but only without ACE‐inhibition. The HR for CVM in the ACE‐inhibitor group were 1.29, 1.28, 1.29 for renin in the first, second and third PP quartiles and 1.22, and 1.19 for aldosterone in the second and fourth quartile. Furthermore, we showed that noradrenaline predicts CVM in all PP quartiles in patients with ACE‐inhibition. In the RAAS‐blocker‐free group, the HR for renin for CVM were 1.36 and 1.18 in the third and fourth PP quartiles, but neither aldosterone nor noradrenaline were predictive for CVM within the PP quartiles. Renin and noradrenaline are strong predictors of CVM regardless of RAAS blockade, whereas aldosterone is predictive only in the ACE‐inhibitor group. Catecholamines but not renin are associated with rising PP.
first_indexed 2024-03-11T14:41:56Z
format Article
id doaj.art-32cda64685864d70ac3ba637e44514ac
institution Directory Open Access Journal
issn 1524-6175
1751-7176
language English
last_indexed 2024-03-11T14:41:56Z
publishDate 2022-12-01
publisher Wiley
record_format Article
series The Journal of Clinical Hypertension
spelling doaj.art-32cda64685864d70ac3ba637e44514ac2023-10-30T13:26:51ZengWileyThe Journal of Clinical Hypertension1524-61751751-71762022-12-0124121587159710.1111/jch.14593The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURICBabak Yazdani0Graciela E. Delgado1Marcus E. Kleber2Gökhan Yücel3Faeq Husain‐Syed4Thomas D. Kraemer5Jan Jochims6Jan Leipe7Winfried März8Bernhard K. Krämer9Fifth Department of Medicine University Medical Center Mannheim UMM Faculty of Medicine of the University of Heidelberg Mannheim GermanyFifth Department of Medicine University Medical Center Mannheim UMM Faculty of Medicine of the University of Heidelberg Mannheim GermanyFifth Department of Medicine University Medical Center Mannheim UMM Faculty of Medicine of the University of Heidelberg Mannheim GermanyFirst Department of Medicine University Medical Center Mannheim UMM Faculty of Medicine of the University of Heidelberg Mannheim GermanySecond Department of Medicine University Medical Center Giessen UKGM Giessen GermanyDepartment of Nephrology and Hypertension Hannover Medical School Hanover GermanyFifth Department of Medicine University Medical Center Mannheim UMM Faculty of Medicine of the University of Heidelberg Mannheim GermanyFifth Department of Medicine University Medical Center Mannheim UMM Faculty of Medicine of the University of Heidelberg Mannheim GermanyFifth Department of Medicine University Medical Center Mannheim UMM Faculty of Medicine of the University of Heidelberg Mannheim GermanyFifth Department of Medicine University Medical Center Mannheim UMM Faculty of Medicine of the University of Heidelberg Mannheim GermanyAbstract Although neurohormones and Renin‐Angiotensin‐Aldosterone‐System (RAAS) components are important predictors of cardiovascular mortality (CVM), their importance for predicting outcomes in patients with/without RAAS‐blockers and different degrees of arterial stiffness is less understood. We therefore analyzed long‐term data from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study in 3316 patients subdivided according to pulse pressure (PP) and RAAS‐blocker use. Patients on RAAS‐inhibition had higher renin and noradrenaline, lower aldosterone and aldosterone/renin quotient (ARQ). Renin and noradrenaline significantly predicted CVM in patients without RAAS‐blocker (HR = 1.17, 1.15) and in patients receiving angiotensin‐converting‐enzyme (ACE) inhibitors (HR = 1.17, 1.29), whereas aldosterone predicted CVM only in patients receiving ACE‐inhibitors (HR = 1.13). CVM was predicted independently from PP by renin, noradrenaline and angiotensin II. Independently from RAAS inhibition renin decreased and ARQs increased with rising PP. Furthermore, noradrenaline increased with PP, but only without ACE‐inhibition. The HR for CVM in the ACE‐inhibitor group were 1.29, 1.28, 1.29 for renin in the first, second and third PP quartiles and 1.22, and 1.19 for aldosterone in the second and fourth quartile. Furthermore, we showed that noradrenaline predicts CVM in all PP quartiles in patients with ACE‐inhibition. In the RAAS‐blocker‐free group, the HR for renin for CVM were 1.36 and 1.18 in the third and fourth PP quartiles, but neither aldosterone nor noradrenaline were predictive for CVM within the PP quartiles. Renin and noradrenaline are strong predictors of CVM regardless of RAAS blockade, whereas aldosterone is predictive only in the ACE‐inhibitor group. Catecholamines but not renin are associated with rising PP.https://doi.org/10.1111/jch.14593ACE‐inhibitorsarterial complianceatherosclerosiscardiovascular mortalitynoradrenalinepulse pressure
spellingShingle Babak Yazdani
Graciela E. Delgado
Marcus E. Kleber
Gökhan Yücel
Faeq Husain‐Syed
Thomas D. Kraemer
Jan Jochims
Jan Leipe
Winfried März
Bernhard K. Krämer
The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC
The Journal of Clinical Hypertension
ACE‐inhibitors
arterial compliance
atherosclerosis
cardiovascular mortality
noradrenaline
pulse pressure
title The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC
title_full The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC
title_fullStr The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC
title_full_unstemmed The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC
title_short The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC
title_sort renin angiotensin aldosterone system neurohumoral axis and cardiovascular mortality in luric
topic ACE‐inhibitors
arterial compliance
atherosclerosis
cardiovascular mortality
noradrenaline
pulse pressure
url https://doi.org/10.1111/jch.14593
work_keys_str_mv AT babakyazdani thereninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT gracielaedelgado thereninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT marcusekleber thereninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT gokhanyucel thereninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT faeqhusainsyed thereninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT thomasdkraemer thereninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT janjochims thereninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT janleipe thereninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT winfriedmarz thereninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT bernhardkkramer thereninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT babakyazdani reninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT gracielaedelgado reninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT marcusekleber reninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT gokhanyucel reninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT faeqhusainsyed reninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT thomasdkraemer reninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT janjochims reninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT janleipe reninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT winfriedmarz reninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric
AT bernhardkkramer reninangiotensinaldosteronesystemneurohumoralaxisandcardiovascularmortalityinluric